Document de travail

Prescription Opioids and Economic Hardship in France

Ilaria Natali, Mathias Dewatripont, Victor Ginsburgh, Michel Goldman et Patrick Legros

Résumé

This paper studies how opioid analgesic sales are empirically related to socioeconomic disparities in France, with a focus on poverty. This analysis is made possible using the OpenHealth database, which provides retail sales data for opioid analgesics available on the French market. We exploit firm-level data for each of the 94 departments in Metropolitan France between 2008 and 2017. We show that increases in the poverty rate are associated with increases in sales: a one percentage point increase in poverty is associated with approximately a five percent increase in mild opioid sales. Our analysis further shows that opioid sales are positively related to the share of middle-aged people and individuals with basic education only, while they are negatively related to population density. The granularity and longitudinal nature of these data allow us to control for a large pool of potential confounding factors. Our results suggest that additional interventions should be more intensively addressed towards the most deprived areas. We conclude that a combination of policies aimed at improving economic prospects and strictly monitoring access to opioid medications would be beneficial for reducing opioid-related harm.

Référence

Ilaria Natali, Mathias Dewatripont, Victor Ginsburgh, Michel Goldman et Patrick Legros, « Prescription Opioids and Economic Hardship in France », TSE Working Paper, n° 22-1388, décembre 2022.

Voir aussi

Publié dans

TSE Working Paper, n° 22-1388, décembre 2022